GABRB3
GABRB3 is a gene that encodes the beta 3 subunit of the gamma-aminobutyric acid (GABA) A receptor in the human body. This receptor is a member of the ligand-gated ion channel family, which plays a crucial role in inhibitory neurotransmission.
Function[edit | edit source]
The GABRB3 gene is part of the GABA_A receptor, a pentameric structure composed of five subunits. The beta 3 subunit, encoded by GABRB3, is one of the possible subunits that can be incorporated into the receptor. The GABA_A receptor is the primary inhibitory neurotransmitter receptor in the brain. When activated by GABA, it allows the influx of chloride ions into the neuron, which leads to hyperpolarization of the cell and an overall decrease in neuronal excitability.
Clinical Significance[edit | edit source]
Mutations in the GABRB3 gene have been associated with several neurological and psychiatric disorders. These include childhood absence epilepsy, autism spectrum disorder, angelman syndrome, and prader-willi syndrome.
In the case of childhood absence epilepsy, mutations in GABRB3 can lead to a decrease in GABA_A receptor function, which results in increased neuronal excitability and the characteristic absence seizures.
In autism spectrum disorder, angelman syndrome, and prader-willi syndrome, the role of GABRB3 is less clear. However, it is thought that alterations in GABAergic neurotransmission, possibly due to changes in GABA_A receptor composition or function, may contribute to the cognitive and behavioral abnormalities seen in these disorders.
Research[edit | edit source]
Research into the GABRB3 gene and its associated disorders is ongoing. Current areas of focus include understanding the specific mechanisms by which mutations in GABRB3 lead to disease, as well as developing potential therapeutic strategies for these disorders.
See Also[edit | edit source]
- GABA_A receptor
- Gamma-aminobutyric acid
- Childhood absence epilepsy
- Autism spectrum disorder
- Angelman syndrome
- Prader-Willi syndrome
References[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD